Moody Aldrich Partners’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-39,100
| Closed | -$4.28M | – | 221 |
|
2023
Q4 | $4.28M | Buy |
+39,100
| New | +$4.28M | 0.77% | 57 |
|
2023
Q3 | – | Sell |
-38,810
| Closed | -$5.27M | – | 196 |
|
2023
Q2 | $5.27M | Sell |
38,810
-30
| -0.1% | -$4.08K | 1.02% | 30 |
|
2023
Q1 | $4.03M | Sell |
38,840
-13,045
| -25% | -$1.35M | 0.81% | 49 |
|
2022
Q4 | $4.6M | Sell |
51,885
-20,115
| -28% | -$1.78M | 0.93% | 43 |
|
2022
Q3 | $5.77M | Buy |
72,000
+1,599
| +2% | +$128K | 1.19% | 25 |
|
2022
Q2 | $6.74M | Buy |
70,401
+1,171
| +2% | +$112K | 1.32% | 22 |
|
2022
Q1 | $10.3M | Buy |
69,230
+13,567
| +24% | +$2.02M | 1.45% | 22 |
|
2021
Q4 | $7.89M | Buy |
55,663
+2,406
| +5% | +$341K | 1.1% | 35 |
|
2021
Q3 | $6.97M | Buy |
53,257
+7,590
| +17% | +$993K | 0.88% | 53 |
|
2021
Q2 | $6.28M | Sell |
45,667
-14,326
| -24% | -$1.97M | 0.88% | 52 |
|
2021
Q1 | $7.83M | Buy |
59,993
+988
| +2% | +$129K | 1.13% | 29 |
|
2020
Q4 | $6.61M | Buy |
59,005
+19,114
| +48% | +$2.14M | 1.07% | 33 |
|
2020
Q3 | $3.14M | Buy |
39,891
+12,092
| +43% | +$951K | 0.66% | 71 |
|
2020
Q2 | $2M | Buy |
27,799
+4,079
| +17% | +$294K | 0.43% | 86 |
|
2020
Q1 | $1.36M | Sell |
23,720
-50
| -0.2% | -$2.86K | 0.41% | 85 |
|
2019
Q4 | $2.66M | Buy |
23,770
+206
| +0.9% | +$23K | 0.55% | 75 |
|
2019
Q3 | $2.27M | Sell |
23,564
-270
| -1% | -$26K | 0.6% | 65 |
|
2019
Q2 | $2.04M | Sell |
23,834
-38,745
| -62% | -$3.31M | 0.52% | 73 |
|
2019
Q1 | $5.21M | Buy |
62,579
+36,326
| +138% | +$3.02M | 1.46% | 20 |
|
2018
Q4 | $1.69M | Buy |
26,253
+1,866
| +8% | +$120K | 0.55% | 71 |
|
2018
Q3 | $1.93M | Buy |
24,387
+3,941
| +19% | +$312K | 0.56% | 78 |
|
2018
Q2 | $1.5M | Buy |
+20,446
| New | +$1.5M | 0.53% | 77 |
|